Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Clinical trial NCT02109913 · UNKNOWN

Trial details

NCT number: NCT02109913
Sponsor: Amsterdam UMC, location VUmc
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hormone Receptor Positive Malignant Neoplasm of Breast Metastatic Breast Cancer

Start date: 2014-03-01
Primary completion: 2021-01-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.